222 related articles for article (PubMed ID: 21562245)
1. Confirmation of family cancer history reported in a population-based survey.
Mai PL; Garceau AO; Graubard BI; Dunn M; McNeel TS; Gonsalves L; Gail MH; Greene MH; Willis GB; Wideroff L
J Natl Cancer Inst; 2011 May; 103(10):788-97. PubMed ID: 21562245
[TBL] [Abstract][Full Text] [Related]
2. Family cancer history: healthy skepticism required.
Freedman RA; Garber JE
J Natl Cancer Inst; 2011 May; 103(10):776-7. PubMed ID: 21562244
[No Abstract] [Full Text] [Related]
3. Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.
Mai PL; Wideroff L; Greene MH; Graubard BI
Public Health Genomics; 2010; 13(7-8):495-503. PubMed ID: 20389042
[TBL] [Abstract][Full Text] [Related]
4. Validation of family history data in cancer family registries.
Ziogas A; Anton-Culver H
Am J Prev Med; 2003 Feb; 24(2):190-8. PubMed ID: 12568826
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of family cancer history in breast cancer patients.
Theis B; Boyd N; Lockwood G; Tritchler D
Eur J Cancer Prev; 1994 Jul; 3(4):321-7. PubMed ID: 7950886
[TBL] [Abstract][Full Text] [Related]
6. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention.
Ramsey SD; Yoon P; Moonesinghe R; Khoury MJ
Genet Med; 2006 Sep; 8(9):571-5. PubMed ID: 16980813
[TBL] [Abstract][Full Text] [Related]
7. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
9. Coherence and completeness of population-based family cancer reports.
Wideroff L; Garceau AO; Greene MH; Dunn M; McNeel T; Mai P; Willis G; Gonsalves L; Martin M; Graubard BI
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):799-810. PubMed ID: 20160272
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants.
Abdel-Rahman O
Clin Breast Cancer; 2020 Aug; 20(4):300-306. PubMed ID: 32327298
[TBL] [Abstract][Full Text] [Related]
11. How representative are colorectal, lung, breast and prostate cancer patients responding to the National Cancer Patient Experience Survey (CPES) of the cancer registry population in England? A population-based case control study.
Alessy SA; Davies EA; Rawlinson J; Baker M; Lüchtenborg M
BMJ Open; 2019 Dec; 9(12):e034344. PubMed ID: 31848175
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of family history of cancer as reported by men with prostate cancer.
King TM; Tong L; Pack RJ; Spencer C; Amos CI
Urology; 2002 Apr; 59(4):546-50. PubMed ID: 11927311
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
Goldsbury D; Weber M; Yap S; Banks E; O'Connell DL; Canfell K
BMC Med Inform Decis Mak; 2017 Feb; 17(1):23. PubMed ID: 28241763
[TBL] [Abstract][Full Text] [Related]
15. Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Pinsky PF; Kramer BS; Reding D; Buys S;
Am J Epidemiol; 2003 May; 157(9):792-9. PubMed ID: 12727673
[TBL] [Abstract][Full Text] [Related]
16. Clinically relevant changes in family history of cancer over time.
Ziogas A; Horick NK; Kinney AY; Lowery JT; Domchek SM; Isaacs C; Griffin CA; Moorman PG; Edwards KL; Hill DA; Berg JS; Tomlinson GE; Anton-Culver H; Strong LC; Kasten CH; Finkelstein DM; Plon SE
JAMA; 2011 Jul; 306(2):172-8. PubMed ID: 21750294
[TBL] [Abstract][Full Text] [Related]
17. An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial.
Goldstein KM; Fisher DA; Wu RR; Orlando LA; Coffman CJ; Grubber JM; Rakhra-Burris T; Wang V; Scheuner MT; Sperber N; Datta SK; Nelson RE; Strawbridge E; Provenzale D; Hauser ER; Voils CI
Trials; 2019 Oct; 20(1):576. PubMed ID: 31590688
[TBL] [Abstract][Full Text] [Related]
18. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
19. Validating cancer histories in deceased relatives.
Rauscher GH; Sandler DP
Epidemiology; 2005 Mar; 16(2):262-5. PubMed ID: 15703544
[TBL] [Abstract][Full Text] [Related]
20. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
